Drug Profile
ATG 002
Alternative Names: ATG-002Latest Information Update: 06 Oct 2009
Price :
$50
*
At a glance
- Originator CoMentis
- Class Small molecules
- Mechanism of Action Angiogenesis inducing agents; Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic foot ulcer
Most Recent Events
- 07 Aug 2007 Discontinued - Phase-I/II for Diabetic foot ulcer in USA (Topical)
- 21 Jun 2006 Athenagen has filed an IND with the US FDA for diabetic foot ulcers
- 31 May 2006 Phase-I/II clinical trials in Diabetic foot ulcer in USA (Topical)